Prognosis of synchronous bilateral breast cancer

British Journal of Surgery

Volumn 96, Issue 4, 2009, Pages 376-380

  Irvine, T ^a,b   Allen, D S ^a   Gillett, C ^a   Hamed, H ^a   Fentiman, I S ^a  

^a GUY S HOSPITAL   (United Kingdom)

^b ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; ONSET AGE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; SYNCHRONOUS BILATERAL BREAST CANCER; BREAST TUMOR; CASE CONTROL STUDY; DISEASE FREE SURVIVAL; KAPLAN MEIER METHOD; MASTECTOMY; MIDDLE AGED; MORTALITY; PATHOLOGY; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CASE-CONTROL STUDIES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MASTECTOMY; MIDDLE AGED; PROGNOSIS; TUMOR BURDEN;

EID: 63049111825     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.6553     Document Type: Article

References (30)

1. Numbers of New Cases and Rates by Age, Female Breast Cancer, UK by County. Cancer Research UK, 2004; http://info.cancerresearchuk.org/ cancerstats/incidence/ females/?a=5441 [accessed 22 January 2009].
2. Graham MD, Yelland A, Peacock J, Beck N, Ford H, Gazet JC et al. Bilateral carcinoma of the breast. Eur J Surg Oncol 1993; 19: 259-264.
3. Gogas J, Markopoulos C, Skandalakis P, Gogas H. Bilateral breast cancer. Am Surg 1993; 59: 733-735.
4. Tousimis E. Synchronous bilateral invasive breast cancer. Breast Cancer Online 2005; 8. http://ww.bco.org [accessed 22 January 2009].
5. Marpeau O, Ancel PY, Antoine M, Uzan S, Barranger E. [Synchronous bilateral breast cancer: risk factors, diagnosis, histology and treatment.] Gynecol Obstet Fertil 2008; 36: 35-44.
6. Heaton KM, Peoples GE, Singletary SE, Feig BW, Ross MI, Ames FC et al. Feasibility of breast conservation therapy in metachronous or synchronous bilateral breast cancer. Ann Surg Oncol 1999; 6: 102-108.
7. Newman LA, Sahin AA, Cunningham JE, Bondy ML, Mirza NQ, Vlastos GS et al. A case-control study of unilateral and bilateral breast carcinoma patients. Cancer 2001; 91: 1845-1853.
8. Verkooijen HM, Chatelain V, Fioretta G, Vlastos G, Rapiti E, Sappino AP et al. Survival after bilateral breast cancer: results from a population-based study. Breast Cancer Res Treat 2007; 105: 347-357.
9. Takahashi H, Watanabe K, Takahashi K, Taguchi K, Sasaki F, Todo S. The impact of bilateral breast cancer on the prognosis of breast cancer: a comparative study with unilateral breast cancer. Breast Cancer 2005; 12: 196-202.
10. Jobsen JJ, van der Palen J, Ong F, Meerwaldt JH. Synchronous, bilateral breast cancer: prognostic value and incidence. Breast 2003; 12: 83-88.
11. Carmichael AR, Bendall S, Lockerbie L, Prescott R, Bates T. The long-term outcome of synchronous bilateral breast cancer is worse than metachronous or unilateral tumours. Eur J Surg Oncol 2002; 28: 388-391.
12. Kollias J, Ellis IO, Elston CW, Blamey RW. Prognostic significance of synchronous and metachronous bilateral breast cancer. World J Surg 2001; 25: 1117-1124.
13. Heron DE, Komarnicky LT, Hyslop T, Schwartz GF, Mansfield CM. Bilateral breast carcinomas: risk factors and outcomes for patients with synchronous and metachronous disease. Cancer 2000; 88: 2739-2750.
14. Miles DW, Ryder K, Rubens RD, Fentiman IS, Beechey-Newman N, Hamed H et al. A system to evaluate relapse-free survival (RFS) probabilities and probable benefit from adjuvant therapy in patients (pts) with operable breast cancer. Proceedings of ASCO 2002; 21: 436a.
15. Blamey RW, Ellis IO, Pinder SE, Lee AH, Macmillan RD, Morgan DA et al. Survival of invasive breast cancer according to the Nottingham Prognostic Index in cases diagnosed in 1990-1999. Eur J Cancer 2007; 43: 1548-1555.
16. Gilroy JS, Morris CG, Mendenhall NP. Breast-conserving therapy in patients with bilateral breast cancer: do today's treatment choices burn bridges for tomorrow? Int J Radiat Oncol Biol Phys 2005; 62: 379-385.
17. Yamauchi C, Mitsumori M, Nagata Y, Kokubo M, Inamoto T, Mise K et al. Bilateral breast-conserving therapy for bilateral breast cancer: results and consideration of radiation technique. Breast Cancer 2005; 12: 135-139.
18. Gollamudi SV, Gelman RS, Peiro G, Schneider LJ, Schnitt SJ, Recht A et al. Breast-conserving therapy for stage I-II synchronous bilateral breast carcinoma. Cancer 1997; 79: 1362-1369.
19. Hungness ES, Safa M, Shaughnessy EA, Aron BS, Gazder PA, Hawkins HH et al. Bilateral synchronous breast cancer: mode of detection and comparison of histologic features between the 2 breasts. Surgery 2000; 128: 702-707.
20. Awad AT, el-Husseini G, Anwar M, Abu-Nasr A, Anwar AA, Sakr M. Bilateral primary breast cancers: a clinicopathological study for the second primary. Int Surg 1996; 81: 57-60.
21. Pomerantz RA, Murad T, Hines JR. Bilateral breast cancer. Am Surg 1989; 55: 441-444.
22. Polednak AP. Bilateral synchronous breast cancer: a population-based study of characteristics, method of detection, and survival. Surgery 2003; 133: 383-389.
23. Ozaki S, Tozaki M, Fukuma E, Kawano M, Suzuki T, Yamashiro N et al. Bilateral breast MR imaging: is it superior to conventional methods for the detection of contralateral breast cancer? Breast Cancer 2008; 15: 169-174.
24. Singletary SE, Taylor SH, Guinee VF,Whitworth PW Jr. Occurrence and prognosis of contralateral carcinoma of the breast. J AmColl Surg 1994; 178: 390-396.
25. Gustafsson A, Tartter PI, Brower ST, Lesnick G. Prognosis of patients with bilateral carcinoma of the breast. J Am Coll Surg 1994; 178: 111-116.
26. G̈ ulay H, Hamalodlu E, Bulut O, G̈ oksel HA. Bilateral breast carcinoma: 28 years' experience. World J Surg 1990; 14: 529-533.
27. Mueller CB, Ames F. Bilateral carcinoma of the breast: frequency and mortality. Can J Surg 1978; 21: 459-465.
28. Park SC, Hwang UK, Ahn SH, Gong GY, Yoon HS. Genetic changes in bilateral breast cancer by comparative genetic hybridisation. Clin Exp Med 2007; 7: 1-5.
29. Saad RS, Denning KL, Finkelstein SD, Liu Y, Pereira TC, Lin X et al. Diagnostic and prognostic utility of molecular markers in synchronous bilateral breast carcinomas. Mod Pathol 2008; 21: 1200-1207.
30. Ravdin PM, Siminoff LA, Davis GJ, Mercer MB, Hewlett J, Gerson N et al. Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer. J Clin Oncol 2001; 19: 980-991.